Yixintang Pharmaceutical (SZ:002727) Zheng Quan Zhi Xing·2025-07-02 16:03Summary of Key Points Core Viewpoint - Yixin Tang Pharmaceutical Group Co., Ltd. has provided a guarantee for its wholly-owned subsidiary, Henan Hongxiang Yixin Tang Pharmaceutical Co., Ltd., to secure a credit line of up to 200 million RMB from banks for financing purposes [1][2]. Group 1: Guarantee Overview - The company approved a resolution at the 2024 annual shareholders' meeting on May 21, 2025, to allow its subsidiary to apply for a comprehensive credit line and provide a guarantee [1]. - The guarantee amount is capped at 20 million RMB, with the specific credit limit determined by the bank [1]. Group 2: Progress of Guarantee - A maximum guarantee contract has been signed with Shanghai Pudong Development Bank Co., Ltd. Zhengzhou Branch, providing joint liability guarantee for the subsidiary [1][2]. Group 3: Subsidiary Information - Henan Hongxiang Yixin Tang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary with a registered capital of 105 million RMB, established on April 18, 2000 [2]. - The company operates in various sectors, including drug retail, medical services, and health consulting [2]. Group 4: Financial Indicators - As of March 31, 2025, the total assets of Henan Hongxiang Yixin Tang were approximately 176.18 million RMB, with total liabilities of about 72.28 million RMB, resulting in a net asset value of approximately 103.90 million RMB [3][4]. - The debt-to-asset ratio increased from 40.23% at the end of 2024 to 41.03% by March 31, 2025 [4]. Group 5: Guarantee Agreement Details - The guarantee covers the principal debt and associated costs, including interest, penalties, and other fees related to the contract [4][5]. - The guarantee period is three years from the maturity date of each debt under the main contract [5]. Group 6: Necessity and Reasonableness of Guarantee - The guarantee is deemed necessary for the subsidiary's operational needs and is expected to positively impact the company's development and efficiency [5]. - The subsidiary is reported to have a normal debt repayment capacity, with no significant issues affecting its ability to repay debts [5]. Group 7: Cumulative External Guarantee Amount - After this guarantee, the total external guarantee amount for the company and its subsidiaries is 1.29 billion RMB, with a total outstanding guarantee balance of approximately 855.49 million RMB, which does not exceed the audited net assets for 2024 [5].